Inhibition of mTOR down-regulates scavenger receptor, class B, type i (SR-BI) expression, reduces endothelial cell migration and impairs nitric oxide production

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 7, 2014, Pages 944-953

  Fruhwürth, Stefanie ^a   Krieger, Sigurd ^a   Winter, Katharina ^a   Rosner, Margit ^a   Mikula, Mario ^a   Weichhart, Thomas ^a   Bittman, Robert ^b   Hengstschläger, Markus ^a   Stangl, Herbert ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Cell migration; Endothelial cell; eNOS; HDL; mTOR; SR BI

Indexed keywords

CELL MIGRATION; ENDOTHELIAL CELL; ENOS; HDL; MTOR; SR-BI;

AMINO ACID SEQUENCE; ANTIBIOTICS, ANTINEOPLASTIC; BIOLOGICAL TRANSPORT; CELL MOVEMENT; CHOLESTEROL, HDL; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; RNA, MESSENGER; SCAVENGER RECEPTORS, CLASS B; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84899436184     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.03.014     Document Type: Article

References (39)

1. D.J. Gordon, and B.M. Rifkind High-density lipoprotein - the clinical implications of recent studies N. Engl. J. Med. 321 1989 1311 1316 (Pubitemid 19267219)
2. K.A. Rye, and P.J. Barter Cardioprotective functions of HDL J. Lipid Res. 55 2 2014 168 179
3. D.J. Rader, and A. Daugherty Translating molecular discoveries into new therapies for atherosclerosis Nature 451 2008 904 913 (Pubitemid 351301745)
4. A. von Eckardstein, and L. Rohrer Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins Curr. Opin. Lipidol. 20 2009 197 205
5. M. Laplante, and D.M. Sabatini mTOR signaling in growth control and disease Cell 149 2012 274 293
6. X.M. Ma, and J. Blenis Molecular mechanisms of mTOR-mediated translational control Nat. Rev. Mol. Cell Biol. 10 2009 307 318
7. C.A. Lewis, B. Griffiths, C.R. Santos, M. Pende, and A. Schulze Regulation of the SREBP transcription factors by mTORC1 Biochem. Soc. Trans. 39 2011 495 499
8. M.S. Brown, and J.L. Goldstein The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor Cell 89 1997 331 340 (Pubitemid 27220877)
9. M. Laplante, and D.M. Sabatini An emerging role of mTOR in lipid biosynthesis Curr. Biol. 19 2009 R1046 R1052
10. A.S. Mathis, N. Dave, G.T. Knipp, and G.S. Friedman Drug-related dyslipidemia after renal transplantation Am. J. Health Syst. Pharm. 61 2004 565 585 (quiz 586-567)
11. R.J. Howard, P.R. Patton, A.I. Reed, A.W. Hemming, W.J. Van der Werf, W.W. Pfaff, T.R. Srinivas, and J.C. Scornik The changing causes of graft loss and death after kidney transplantation Transplantation 73 2002 1923 1928 (Pubitemid 34701001)
12. B.L. Kasiske, A. de Mattos, S.M. Flechner, L. Gallon, H.U. Meier-Kriesche, M.R. Weir, and A. Wilkinson Mammalian target of rapamycin inhibitor dyslipidemia in kidney transplant recipients Am. J. Transplant. 8 2008 1384 1392 (Pubitemid 351989497)
13. D. Ai, C. Chen, S. Han, A. Ganda, A.J. Murphy, R. Haeusler, E. Thorp, D. Accili, J.D. Horton, and A.R. Tall Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice J. Clin. Invest. 122 2012 1262 1270
14. M.M. Elloso, N. Azrolan, S.N. Sehgal, P.L. Hsu, K.L. Phiel, C.A. Kopec, M.D. Basso, and S.J. Adelman Protective effect of the immunosuppressant sirolimus against aortic atherosclerosis in apo E-deficient mice Am. J. Transplant. 3 2003 562 569 (Pubitemid 36612839)
15. N. Zhang, D. Su, S. Qu, T. Tse, R. Bottino, A.N. Balamurugan, J. Xu, J.S. Bromberg, and H.H. Dong Sirolimus is associated with reduced islet engraftment and impaired beta-cell function Diabetes 55 2006 2429 2436 (Pubitemid 44871142)
16. C. Mineo, and P.W. Shaul Functions of scavenger receptor class B, type I in atherosclerosis Curr. Opin. Lipidol. 23 2012 487 493
17. L. Rohrer, P.M. Ohnsorg, M. Lehner, F. Landolt, F. Rinninger, and A. von Eckardstein High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1 Circ. Res. 104 2009 1142 1150
18. C. Mineo, and P.W. Shaul Regulation of signal transduction by HDL J. Lipid Res. 54 2013 2315 2324
19. I.S. Yuhanna, Y. Zhu, B.E. Cox, L.D. Hahner, S. Osborne-Lawrence, P. Lu, Y.L. Marcel, R.G. Anderson, M.E. Mendelsohn, H.H. Hobbs, and P.W. Shaul High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase Nat. Med. 7 2001 853 857 (Pubitemid 32691642)
20. C. Mineo, and P.W. Shaul Role of high-density lipoprotein and scavenger receptor B type I in the promotion of endothelial repair Trends Cardiovasc. Med. 17 2007 156 161 (Pubitemid 46898843)
21. C. Mineo, I.S. Yuhanna, M.J. Quon, and P.W. Shaul High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases J. Biol. Chem. 278 2003 9142 9149 (Pubitemid 36800395)
22. V.N. Schumaker, and D.L. Puppione Sequential flotation ultracentrifugation Methods Enzymol. 128 1986 155 170 (Pubitemid 16100890)
23. C. Rohrl, C. Meisslitzer-Ruppitsch, R. Bittman, Z. Li, G. Pabst, R. Prassl, W. Strobl, J. Neumuller, A. Ellinger, M. Pavelka, and H. Stangl Combined light and electron microscopy using diaminobenzidine photooxidation to monitor trafficking of lipids derived from lipoprotein particles Curr. Pharm. Biotechnol. 13 2012 331 340
24. R.E. Pitas, T.L. Innerarity, J.N. Weinstein, and R.W. Mahley Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy Arteriosclerosis 1 1981 177 185 (Pubitemid 11024320)
25. H. Stangl, M. Hyatt, and H.H. Hobbs Transport of lipids from high and low density lipoproteins via scavenger receptor-BI J. Biol. Chem. 274 1999 32692 32698 (Pubitemid 129535297)
26. H. Kojima, K. Sakurai, K. Kikuchi, S. Kawahara, Y. Kirino, H. Nagoshi, Y. Hirata, and T. Nagano Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore Pharm. Bull. 46 1998 373 375 (Pubitemid 28124233)
27. D.W. Lamming, and D.M. Sabatini A Central Role for mTOR in Lipid Homeostasis Cell Metab. 18 4 2013 465 469
28. D.D. Sarbassov, S.M. Ali, S. Sengupta, J.H. Sheen, P.P. Hsu, A.F. Bagley, A.L. Markhard, and D.M. Sabatini Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB Mol. Cell 22 2006 159 168
29. J.L. Owen, Y. Zhang, S.H. Bae, M.S. Farooqi, G. Liang, R.E. Hammer, J.L. Goldstein, and M.S. Brown Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase Proc. Natl. Acad. Sci. U. S. A. 109 40 2012 16184 16189
30. A. Leiva, H. Verdejo, M.L. Benitez, A. Martinez, D. Busso, and A. Rigotti Mechanisms regulating hepatic SR-BI expression and their impact on HDL metabolism Atherosclerosis 217 2011 299 307
31. C. Cavelier, P.M. Ohnsorg, L. Rohrer, and A. von Eckardstein The beta-chain of cell surface F(0)F(1) ATPase modulates apoA-I and HDL transcytosis through aortic endothelial cells Arterioscler. Thromb. Vasc. Biol. 32 2012 131 139
32. L.O. Martinez, S. Jacquet, J.P. Esteve, C. Rolland, E. Cabezon, E. Champagne, T. Pineau, V. Georgeaud, J.E. Walker, F. Terce, X. Collet, B. Perret, and R. Barbaras Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis Nature 421 2003 75 79 (Pubitemid 36077087)
33. S.C. Moss, D.J. Lightell Jr., S.O. Marx, A.R. Marks, and T.C. Woods Rapamycin regulates endothelial cell migration through regulation of the cyclin-dependent kinase inhibitor p27Kip1 J. Biol. Chem. 285 2010 11991 11997
34. A.P. Dantas, J. Igarashi, and T. Michel Sphingosine 1-phosphate and control of vascular tone Am. J. Physiol. Heart Circ. Physiol. 284 2003 H2045 H2052
35. B. Levkau Sphingosine-1-phosphate in the regulation of vascular tone: a finely tuned integration system of S1P sources, receptors, and vascular responsiveness Circ. Res. 103 2008 231 233
36. D. Seetharam, C. Mineo, A.K. Gormley, L.L. Gibson, W. Vongpatanasin, K.L. Chambliss, L.D. Hahner, M.L. Cummings, R.L. Kitchens, Y.L. Marcel, D.J. Rader, and P.W. Shaul High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I Circ. Res. 98 2006 63 72 (Pubitemid 43970204)
37. M. Ouimet, V. Franklin, E. Mak, X. Liao, I. Tabas, and Y.L. Marcel Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase Cell Metab. 13 2011 655 667
38. L. Zhao, T. Ding, T. Cyrus, Y. Cheng, H. Tian, M. Ma, R. Falotico, and D. Pratico Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor Br. J. Pharmacol. 156 2009 774 785
39. C. Mineo, and P.W. Shaul Functions of scavenger receptor class B, type I in atherosclerosis Curr. Opin. Lipidol. 23 5 2012 487 493